In the article by Nishimura et al, “2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” which published online March 3, 2014, in Circulation and appears in the June 10, 2014, issue of the journal (Circulation. 2014;129:e521–e643), a correction was needed.
In Table 5, second row, under “Dosage,” the dosage for Penicillin V potassium read, “200 mg orally BID.” It has been changed to read, “250 mg orally BID.”
The table, as corrected, is reproduced below.
This correction has been made to the current online version of the article, which is available at http://circ.ahajournals.org/content/129/23/e521.full.pdf.
- © 2014 American Heart Association, Inc.